| Recruiting | A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH) Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia | Phase 2 / Phase 3 | 2026-01-22 |
| Recruiting | A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia | Phase 3 | 2025-12-11 |
| Recruiting | A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Othe SST2-positive Neuroendocrine Neoplasms, Neuroendocrine Tumors, Neuroendocrine Neoplasm | Phase 1 / Phase 2 | 2025-11-26 |
| Recruiting | Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen Carcinoid Syndrome, Carcinoid, Carcinoid Tumor | Phase 3 | 2025-11-19 |
| Completed | A Study to Assess Pharmacokinetics, Safety, and Tolerability of Atumelnant in Healthy Japanese and Caucasian P Healthy Volunteers | Phase 1 | 2025-10-28 |
| Recruiting | An Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894 Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia | Phase 2 | 2025-02-25 |
| Recruiting | A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome Cushing Syndrome, Cushing Disease, Ectopic ACTH Syndrome | Phase 1 / Phase 2 | 2023-10-12 |
| Completed | Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperp Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia | Phase 2 | 2023-07-03 |
| Completed | Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome Carcinoid Syndrome, Carcinoid, Carcinoid Tumor | Phase 2 | 2022-04-22 |
| Active Not Recruiting | A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2) Acromegaly | Phase 3 | 2021-12-17 |
| Active Not Recruiting | A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly Acromegaly | Phase 3 | 2021-05-12 |
| Completed | Single and Multiple-Ascending Dose Study of CRN04894 in Healthy Volunteers Healthy Volunteers | Phase 1 | 2020-12-18 |
| Active Not Recruiting | A Study to Evaluate the Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Acromegaly | Phase 2 | 2020-01-29 |
| Completed | Mass Balance and Pharmacokinetics of [14C]-CRN00808 in Healthy Volunteers Healthy Volunteers | Phase 1 | 2019-09-17 |
| Completed | A Single and Multiple-Ascending Dose Study of CRN01941 in Healthy Adult Volunteers Healthy Volunteers | Phase 1 | 2019-04-29 |
| Completed | An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge) Acromegaly | Phase 2 | 2019-03-12 |
| Completed | A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve) Acromegaly | Phase 2 | 2019-03-11 |
| Completed | Single and Multiple-Ascending Dose Study of CRN00808 in Healthy Volunteers Healthy Volunteers | Phase 1 | 2017-09-22 |